HCPCS code J2356 — Inj tezepelumab-ekko, 1mg. Status: Active. Effective Jul 1, 2022. Source: CMS HCPCS Level II.

J2356

Active

Inj tezepelumab-ekko, 1mg

Injection, tezepelumab-ekko, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9008

MUE — Medically Unlikely Edits

Maximum units of J2356 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 210
Practitioner Services 210

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
55513-0112-01 Tezspire
55513-0123-01 Tezspire

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q3
    Inj tezepelumab-ekko, 1mg